Huaren Pharmaceutical Co (SZSE:300110) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Huaren Pharmaceutical Co Change In Payables And Accrued Expense?

Huaren Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was ¥0 Mil. It means Huaren Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Huaren Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Huaren Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Huaren Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Huaren Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huaren Pharmaceutical Co Change In Payables And Accrued Expense Chart

Huaren Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Huaren Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Huaren Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Huaren Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Huaren Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Huaren Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huaren Pharmaceutical Co Ltd (SZSE:300110) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100

Website

http://www.qdhuaren.com

Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.

Executives

Yang Xiao Dong	Director
Bo Guo Xiu	Executives
Zhou Xi Jian	Director
Mao Yu Wei	Supervisors
Chu Xiao Jun	Executives
Zhou Qiang	Directors, executives
Ji Sheng Bin	Executives
Xiao Wei Wen	Executives
Shen Hong Ce	Executives
Li Xiao Li	Executives
Liu Qian	Executives
Wang Wen Ping	Executives
Liang Fu You	Director
Liang Fu Dong	Director
Gong Ling	Secretary Dong

Huaren Pharmaceutical Co Headlines

No Headlines